Hyper-responsive phenotype in localized aggressive periodontitis

Journal of Dental Research

Volumn 89, Issue 2, 2010, Pages 143-148

  Shaddox, L ^a,b   Wiedey, J ^a   Bimstein, E ^b   Magnuson, I ^b   Clare Salzler, M ^c   Aukhil, I ^a   Wallet, S M ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Chemokines; Cytokines; Immunity; Inflammation; LAgP; TLR

Indexed keywords

BACTERIAL ANTIGEN; CHEMOKINE; CYTOKINE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGGRESSIVE PERIODONTITIS; ARTICLE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CHILD; DRUG POTENTIATION; ESCHERICHIA COLI; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; PHENOTYPE; PORPHYROMONAS GINGIVALIS; PRESCHOOL CHILD; REGRESSION ANALYSIS;

ADOLESCENT; AFRICAN AMERICANS; AGGRESSIVE PERIODONTITIS; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINES; CHILD; CHILD, PRESCHOOL; CYTOKINES; ESCHERICHIA COLI; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; PHENOTYPE; PORPHYROMONAS GINGIVALIS; REGRESSION ANALYSIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 75649110051     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034509353397     Document Type: Article

References (25)

1. Akira S., Uematsu S., Takeuchi O. (2006). Pathogen recognition and innate immunity. Cell 124: 783-801.
2. Armitage GC (1999). Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4: 1-6.
3. Baker PJ (2000). The role of immune responses in bone loss during periodontal disease. Microbes Infect 2: 1181-1192.
4. Bendre MS, Montague DC, Peery T., Akel NS, Gaddy D., Suva LJ (2003). Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 33: 28-37.
5. Chadwick VS, Chen W., Shu D., Paulus B., Bethwaite P., Tie A., et al. (2002). Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122: 1778-1783.
6. Choi SJ, Cruz JC, Craig F., Chung H., Devlin RD, Roodman GD, et al. (2000). Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96: 671-675.
7. Devaraj S., Dasu MR, Rockwood J., Winter W., Griffen SC, Jialal I. (2008). Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 93: 578-583.
8. Garlet GP, Martins W. Jr, Ferreira BR, Milanezi CM, Silva JS (2003). Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 38: 210-217.
9. Gemmell E., Carter CL, Seymour GJ (2001). Chemokines in human periodontal disease tissues. Clin Exp Immunol 125: 134-141.
10. Han JH, Choi SJ, Kurihara N., Koide M., Oba Y., Roodman GD (2001). Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 97: 3349-3353.
11. Hanazawa S., Kawata Y., Takeshita A., Kumada H., Okithu M., Tanaka S., et al. (1993). Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 61: 5219-5224.
12. Kabashima H., Yoneda M., Nagata K., Hirofuji T., Maeda K. (2002). The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues. Cytokine 20: 70-77.
13. Kim F., Pham M., Luttrell I., Bannerman DD, Tupper J., Thaler J., et al. (2007). Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 100: 1589-1596.
14. Kinane DF, Lappin DF (2001). Clinical, pathological and immunological aspects of periodontal disease. Acta Odontol Scand 59: 154-160.
15. Meng H., Xu L., Li Q., Han J., Zhao Y. (2007). Determinants of host susceptibility in aggressive periodontitis. Periodontol 2000 43: 133-159.
16. Mohammad MK, Morran M., Slotterbeck B., Leaman DW, Sun Y., Grafenstein H., et al. (2006). Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol 18: 1101-1113 ; erratum in Int Immunol 19: 581, 2007.
17. Naguib G., Al- Mashat H., Desta T., Graves DT (2004). Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 123: 87-92.
18. Salvi GE, Collins JG, Yalda B., Arnold RR, Lang NP, Offenbacher S. (1997 a). Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 24: 8-16.
19. Salvi GE, Yalda B., Collins JG, Jones BH, Smith FW, Arnold RR, et al. (1997 b). Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 68: 127-135.
20. Shi H., Kokoeva MV, Inouye K., Tzameli I., Yin H., Flier JS (2006). TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015-3025.
21. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ (2007). Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 86: 306-319.
22. Southerland JH, Taylor GW, Moss K., Beck JD, Offenbacher S. (2006). Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease. Periodontol 2000 40: 130-143.
23. Yamamoto M., Kawabata K., Fujihashi K., McGhee JR, Van Dyke TE, Bamberg TV, et al. (1996). Absence of exogenous interleukin-4-induced apoptosis of gingival macrophages may contribute to chronic inflammation in periodontal diseases. Am J Pathol 148: 331-339.
24. Yoshimura T., Matsushima K., Tanaka S., Robinson EA, Appella E., Oppenheim JJ, et al. (1987). Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84: 9233-9237.
25. Young LR, Borchers MT, Allen HL, Gibbons RS, McCormack FX (2006). Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome. J Immunol 176: 4361-4368.